Literature DB >> 3342967

Irreversible injury in anoxic hepatocytes precipitated by an abrupt increase in plasma membrane permeability.

B Herman1, A L Nieminen, G J Gores, J J Lemasters.   

Abstract

Using low-light digitized video microscopy, the onset, progression, and reversibility of anoxic injury were assessed in single hepatocytes isolated from fasted rats. Cell-surface bleb formation occurred in three stages over 1-3 h after anoxia. Stage I was characterized by formation of numerous small blebs. In stage II, small blebs enlarged by coalescence and fusion to form a few large terminal blebs. Near the end of stage II, cells began to swell rapidly, ending with the apparent breakdown of one of the terminal blebs. Breakdown of the bleb membrane initiated stage III of injury and was coincident with a rapid increase of nonspecific permeability to organic cationic and anionic molecules. On reoxygenation, stages I and II were fully reversible, and plasma membrane blebs were resorbed completely within 6 min of reoxygenation without loss of viability. Stage III, however, was not reversible, and no morphological changes occurred on reoxygenation. The results indicate that onset of cell death owing to anoxia is a rapid event initiated by a sudden increase of nonspecific plasma membrane permeability caused by rupture of a terminal bleb. Anoxic injury is reversible until this event occurs.

Entities:  

Mesh:

Year:  1988        PMID: 3342967     DOI: 10.1096/fasebj.2.2.3342967

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  32 in total

1.  Mucosal vascular stasis precedes loss of viability of endothelial cells in rat acetic acid colitis.

Authors:  F W Leung; A Koo
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  Late steady increase in cytosolic Ca2+ preceding hypoxic injury in hepatocytes.

Authors:  M Brecht; C Brecht; H De Groot
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

3.  Minocycline and doxycycline, but not other tetracycline-derived compounds, protect liver cells from chemical hypoxia and ischemia/reperfusion injury by inhibition of the mitochondrial calcium uniporter.

Authors:  Justin Schwartz; Ekhson Holmuhamedov; Xun Zhang; Gregory L Lovelace; Charles D Smith; John J Lemasters
Journal:  Toxicol Appl Pharmacol       Date:  2013-09-05       Impact factor: 4.219

4.  Betanodavirus: Mitochondrial disruption and necrotic cell death.

Authors:  Jiann-Ruey Hong
Journal:  World J Virol       Date:  2013-02-12

5.  Effects of putative modulators of relaxation microinjected into intact amphibian smooth muscle cells.

Authors:  F S Fay; W C Granger; H H Shelvin; S R Taylor
Journal:  J Physiol       Date:  1991-10       Impact factor: 5.182

6.  Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials.

Authors:  Eileen Pedraza; Maria M Coronel; Christopher A Fraker; Camillo Ricordi; Cherie L Stabler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

7.  Cellular blebbing in superficial colonic epithelial cells occurring with murine graft-versus-host disease.

Authors:  M L Eigenbrodt; J S Kneitz; D L Thiele; E H Eigenbrodt
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  The protection of hepatocyte cells from the effects of oxidative stress by treatment with vitamin E in conjunction with DTT.

Authors:  Jen-Hsiang Tsai; Haw-Wen Chen; Yi-Wan Chen; Jer-Yuh Liu; Chong-Kuei Lii
Journal:  J Biomed Biotechnol       Date:  2010-05-18

9.  Protection from hypoxic injury in cultured hepatocytes by glycine, alanine, and serine.

Authors:  M Brecht; H de Groot
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

10.  C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.

Authors:  Amrom E Obstfeld; Eiji Sugaru; Marie Thearle; Anne-Marie Francisco; Constance Gayet; Henry N Ginsberg; Eleanore V Ables; Anthony W Ferrante
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.